Greenwich LifeSciences (GLSI) News Today $11.27 -0.41 (-3.51%) Closing price 09/16/2025 04:00 PM EasternExtended Trading$11.26 0.00 (-0.04%) As of 09/16/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GLSI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Greenwich LifeSciences: Fast Track Designation Does Not Solve Fundamental IssuesSeptember 16 at 11:56 AM | seekingalpha.comGreenwich LifeSciences granted Fast Track designation for GLSI-100 by FDASeptember 10, 2025 | msn.comGreenwich LifeSciences, Inc.: Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track DesignationSeptember 10, 2025 | finanznachrichten.deGreenwich LifeSciences jumps on FDA fast track for breast cancer therapySeptember 10, 2025 | in.investing.comGreenwich LifeSciences Shares Soar After FDA Grants Fast Track for Breast Cancer TherapySeptember 10, 2025 | msn.comGreenwich LifeSciences soars on FDA Fast Track status for lead assetSeptember 10, 2025 | msn.comGreenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track DesignationSeptember 10, 2025 | finance.yahoo.comGreenwich LifeSciences, Inc. Receives FDA Fast Track Designation for GLSI-100 to Prevent Breast Cancer RecurrencesSeptember 10, 2025 | quiverquant.comQGreenwich LifeSciences' GLSI-100 Granted US FDA Fast Track DesignationSeptember 10, 2025 | globenewswire.comWhat is Noble Financial's Forecast for GLSI Q3 Earnings?August 24, 2025 | marketbeat.comNoble Financial Begins Coverage on Greenwich LifeSciences (NASDAQ:GLSI)August 22, 2025 | marketbeat.comGreenwich LifeSciences initiated with an Outperform at Noble CapitalAugust 20, 2025 | msn.comGreenwich LifeSciences, Inc. Gains Coverage from Noble Capital Markets Amid Phase III Trial of GLSI-100 for Breast CancerAugust 20, 2025 | quiverquant.comQNoble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciencesAugust 20, 2025 | globenewswire.comGreenwich LifeSciences to build out internal clinical trial operations teamAugust 20, 2025 | msn.comGreenwich LifeSciences, Inc. Expands Internal Clinical Trial Management Team for FLAMINGO-01 Phase III StudyAugust 19, 2025 | quiverquant.comQGreenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations TeamAugust 19, 2025 | globenewswire.comGreenwich LifeSciences (NASDAQ:GLSI) Announces Quarterly Earnings ResultsAugust 18, 2025 | marketbeat.comOwning 53% in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) means that insiders are heavily invested in the company's futureAugust 16, 2025 | finance.yahoo.comGreenwich LifeSciences Announces Expansion of Flamingo-01 into RomaniaAugust 13, 2025 | globenewswire.comGreenwich LifeSciences (NASDAQ:GLSI) Stock Price Up 2.5% - Still a Buy?August 12, 2025 | marketbeat.comGreenwich LifeSciences, Inc. Provides Update on CEO Interviews and Corporate Events Related to GLSI-100 DevelopmentAugust 11, 2025 | quiverquant.comQGreenwich LifeSciences Provides Update on CEO Interviews & Corporate EventsAugust 11, 2025 | globenewswire.comGreenwich LifeSciences (GLSI) Expected to Announce Quarterly Earnings on WednesdayAugust 7, 2025 | marketbeat.comGreenwich LifeSciences (NASDAQ:GLSI) Shares Down 5.8% - Should You Sell?July 19, 2025 | marketbeat.comGreenwich LifeSciences (NASDAQ:GLSI) Stock Price Down 0.2% - What's Next?June 21, 2025 | marketbeat.comGreenwich LifeSciences: What The Recent Data Do For The Investment ThesisMay 9, 2025 | seekingalpha.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest UpdateMay 5, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases $35,568.00 in StockMay 1, 2025 | marketbeat.comSnehal Patel Buys 3,600 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockApril 30, 2025 | insidertrades.comResearch Analysts Set Expectations for GLSI Q1 EarningsApril 25, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Buys $48,492.00 in StockApril 24, 2025 | marketbeat.comHC Wainwright Boosts Greenwich LifeSciences (NASDAQ:GLSI) Price Target to $39.00April 23, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Purchases 5,400 SharesApril 23, 2025 | insidertrades.comGreenwich LifeSciences price target raised to $39 from $38 at H.C. WainwrightApril 22, 2025 | markets.businessinsider.comGreenwich LifeSciences (NASDAQ:GLSI) Releases Earnings ResultsApril 17, 2025 | marketbeat.comGreenwich LifeSciences (GLSI) Expected to Announce Earnings on MondayApril 15, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires $32,760.00 in StockApril 10, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires $48,015.00 in StockApril 9, 2025 | marketbeat.comInsider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases 3,600 Shares of StockApril 9, 2025 | insidertrades.comSnehal Patel Acquires 5,500 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockApril 8, 2025 | insidertrades.comGreenwich LifeSciences Provides Global Update on FLAMINGO-01April 3, 2025 | globenewswire.comGreenwich LifeSciences announces ‘positive’ data from FLAMINGO-01 trialApril 3, 2025 | markets.businessinsider.comGreenwich Life rises on data from late-stage trial for breast cancer vaccineApril 2, 2025 | msn.comGreenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical TrialApril 2, 2025 | globenewswire.comGreenwich LifeSciences (NASDAQ:GLSI) Trading Down 6.7% - Here's What HappenedApril 1, 2025 | marketbeat.comGreenwich LifeSciences Delays Yearly Report FilingMarch 31, 2025 | tipranks.comGreenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026March 27, 2025 | globenewswire.comGreenwich LifeSciences provides update on FLAMINGO-01 trialMarch 17, 2025 | markets.businessinsider.comGreenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01March 17, 2025 | globenewswire.com Get Greenwich LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GLSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GLSI Media Mentions By Week GLSI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLSI News Sentiment▼0.350.92▲Average Medical News Sentiment GLSI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLSI Articles This Week▼102▲GLSI Articles Average Week Get the Latest News and Ratings for GLSI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies OPT News Today ARVN News Today OLMA News Today KOD News Today ATYR News Today AQST News Today ESPR News Today IVA News Today RAPP News Today CYRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLSI) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLSI Stock Alerts